Total Medical Supply Inc.’s Post

Have you heard of brain organoids? At PLG, we’re excited to host a Regulatory Panel Discussion in the heart of Paris at Future4Care in collaboration with EIT Health, one of our trusted partners. This thematic working group brings together diverse experts to foster research collaborations and explore the responsible development of brain organoids. As this field continues to shape neuroscience and personalized medicine, it’s crucial to address ethical concerns, patient safety, and regulatory challenges. This roundtable will provide a platform for thought leaders to collaborate on actionable insights that ensure the technology benefits society while upholding ethical standards. At PLG, we work with our R&I department to develop and bring added value to your ecosystem. We enable the future of healthcare by innovating, transforming, and adapting. Join the conversation and discover how PLG innovates in healthcare with our R&I department. ➡️ Visit our page to learn more: https://lnkd.in/drXzi2UY #innovation #pharma #regulatory #paneldiscussion #research #brainorganoids #safety #healthcare

There are moments when the sense of experiencing a period of rapid, tangible, and exhilarating transformation within your team is undeniable. Projects like these make working in the healthcare sector both rewarding and stimulating. We are excited (really, I mean it!) to announce that GEK Lab will be collaborating with MADE - Competence Center Industry 4.0 and its ecosystem, particularly with partners University of Brescia, Politecnico di Milano, and CSMT Innovative Contamination Hub to develop an innovative electrochemical biosensor for diabetes monitoring and the identification of prediabetes and related metabolic disorders. This project represents a significant step forward in clinical diagnostics and the personalization of treatment for metabolic diseases. The project is co-financed with PNRR funds. #Innovation #Healthcare #Biosensors #MADE4.0 #GEKLab #UniversityofBrescia #PolitecnicoDiMilano #Diagnostics #Research #DiabetesManagement #NextGenerationEU

On #ClinicalTrialsDay, we highlight the crucial role of clinical trials in advancing medical science and improving patient care. These trials are foundational in evaluating new treatments, determining their effectiveness, and ensuring patient safety, driving forward the innovation in healthcare. The Importance of Diversity in Clinical Trials: Diversity in clinical trials is essential for several key reasons: - **Genetic Variations:** Different responses to treatments across diverse genetic backgrounds underline the need for personalized medical solutions. - **Wider Applicability:** Including a variety of participants ensures the results can be generalized to a broader population, making the findings more reliable and applicable universally. - **Equity in Healthcare:** A diverse participant pool in clinical research promotes equity, ensuring all population segments have access to advanced treatments and contributing to reducing health disparities. International Clinical Trials Day serves as a reminder of the importance of inclusivity in clinical research. By prioritizing diversity, we can ensure that healthcare advancements benefit everyone, leading to a healthier, more equitable future. #CTD2024 PPD Thermo Fisher Scientific CorEvitas, LLC #Research #DEI

The rapid advancements in healthcare and clinical research across various therapeutic areas are truly inspiring. As someone with a background in clinical research, I’m excited to see how innovations in different fields are driving transformative changes in patient care. Whether it's through breakthroughs in drug development, personalized medicine, or novel clinical trial designs, these advancements motivate me to continue learning and contributing to the evolving landscape of healthcare. What recent innovations in healthcare or clinical research have caught your attention? Let’s discuss and share insights on how we can collectively drive impactful change in patient outcomes.

🎙️ Listen now! https://apple.co/3OkvHCA & https://bit.ly/3ADUjTZ Join Professor Kathryn Whitehead of Carnegie Mellon as she shares her groundbreaking work on drug delivery, LNPs, and maternal health. Learn why science communication drives innovation. Key Highlights: • Drug delivery poses a significant therapeutic challenge with exciting opportunities to innovate. • Harnessing emotion can drive the pursuit of new ideas. • Effective science communication accelerates breakthroughs. #BackOfTheNapkin #BioTechne #DrugDelivery #Innovation #LNPs #SciencePodcast #MaternalHealth

Consumers expect more out of #pharma and #lifesciences. The industry is held to a higher standard than others - one where we are not just responsible for making medicines, but for solving societal problems. Given that 80% of health outcomes are attributable to factors outside of clinical care, what is the life science industry's locus of responsibility? Healthcare solutions - whether medicines or medical devices - do not have a chance if the 80% is not understood and taken into account along each step of the drug development journey. Please join us in widening the industry's lens and tune in to Luminous recent podcast with Patients As Partners in Clinical Research Community News in which we discuss the benefits of a #biopsychosocial approach to medicine development in improving outcomes for patients, business and society. We'll dive into emerging methodologies, such as applied biosemiotics, and how we can combine principles from the social sciences with those in the life sciences to improve therapeutic development and delivery. I continue to be inspired by our life sciences clients who are embracing their social responsibility in a meaningful and impactful way. A big thank you to the The Conference Forum team for your support and for this important dialogue. Looking forward to the #PatientsAsPartners conference this month! Danny McCarthy Elizabeth Bard Valerie Bowling https://lnkd.in/ewpWyHr3 #patientvoice

Great panel this morning at DPHARM: Disruptive Innovations to Modernize Clinical Research on Solving Big Problems in Clinical Trials, moderated by Nick Slack, MBE. I appreciate the comments by Zachary Sigal, Jim Murphy, Andy Lee, Bari Kowal, Shoibal Datta, and Peyton Howell. Key insights: 1. Have to seek not only incremental change but also dramatic change 2. Must streamline data collection 3. Patients are traveling 40% further than before 4. Be more patient-centric and site-centric in the protocol design

In recent years, innovations in clinical trials have transformed the way we develop new therapies, making the process faster, more efficient and more patient-centered. Here are some of the most exciting advancements that are reshaping clinical research 🚀 👉 Innovations like these are not only making clinical trials more efficient and effective but also improving patient experience and accelerating the development of new, life-saving therapies. As these trends continue to evolve, the future of clinical research holds tremendous potential for advancing healthcare worldwide 🌍

This week, we interview William Hind, CEO of Alpharmaxim Healthcare Communications, on their innovative Healthcare Behaviour Insights Tool (H-BIT) developed with Aston University. 🧠💡 Discover how H-BIT uses behavioral science to address barriers in adopting new medical therapies and its potential impact on the pharma sector. Get insights into the inspiration behind the tool, overcoming challenges, and tips for aspiring leaders. https://lnkd.in/dUEBw4kF

A great summary of how the investment/innovation/reward cycle works. Captures the antibiotic problem painfully well. Reward too small, innovation/investment smaller. Fix this problem by unlocking value/reward and the insurance (DRG) problem. Fix the US market first and the whole world benefits.